About OMEROS CORPORATION
Omeros is a biopharmaceutical company focused on developing next-generation therapeutics through innovative and cutting-edge science, targeting unmet medical needs with first-in-class drugs.
Development of small-molecule and protein therapeuticsResearch in adoptive T cell therapies and CAR TGPCR platform developmentPipeline of first-in-class drugs with new mechanisms of action
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to OMEROS CORPORATION right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.